The primary pain point is manual inefficiency. Clinical research coordinators spend up to 30% of their time manually screening patient records against dense, complex eligibility criteria. This leads to slow enrollment, high screen-out rates, and missed opportunities to match eligible patients. The result is extended trial timelines, costing sponsors millions per day in delayed revenue and delaying patient access to novel therapies. This manual process also inherently limits trial diversity, as it cannot efficiently scan broad, heterogeneous patient populations.
Use Case
AI-Powered Clinical Trial Matching

Traditional clinical trial recruitment is a costly, manual process that delays life-saving treatments and reduces trial diversity. AI-powered matching automates this critical bottleneck.
The AI fix automates this screening. By applying Natural Language Processing (NLP) and structured logic, AI systems instantly parse electronic health records (EHRs) and match patients to trials. This accelerates enrollment by 40-70%, dramatically cuts screening costs, and enables sponsors to cast a wider net across diverse care settings. The measurable outcome is faster time-to-market for new drugs and more representative trial populations, directly improving ROI and regulatory compliance. For a deeper dive into how AI synthesizes patient data for personalized care, explore our insights on Personalized Treatment Plan Generation.
Core Business Use Cases for AI Matching
Transform patient recruitment from a costly, manual bottleneck into a strategic, data-driven accelerator. These use cases demonstrate how AI directly impacts trial timelines, diversity, and cost.
Accelerate Patient Enrollment
Manual screening of patient records against hundreds of complex eligibility criteria is a primary cause of trial delays. AI automates this process, analyzing structured and unstructured EHR data in seconds to identify potential matches.
- Reduces screening time from weeks to minutes per patient.
- Increases screen-to-randomization rates by surfacing patients who would be missed in manual reviews.
- Real-world impact: A mid-sized biotech reduced enrollment time for a Phase III oncology trial by 34%, saving an estimated $2.1M in operational costs and accelerating time-to-market.
Increase Trial Diversity & Reach
Homogeneous trial populations limit drug applicability and can delay regulatory approval. AI expands the search beyond major academic centers to community hospitals and diverse patient populations.
- Analyzes broader, real-world data to identify eligible patients across geographies and demographics.
- Mitigates selection bias by applying criteria consistently across all records.
- Business justification: Enhances the representativeness of trial data, strengthening regulatory submissions and expanding the addressable market for the therapy upon approval. This is a key component of modern clinical trial matching strategy.
Optimize Site Selection & Performance
Choosing underperforming trial sites is a multi-million dollar mistake. AI predicts site performance by analyzing historical enrollment data, local patient demographics, and site capabilities.
- Prioritizes high-potential sites before contract execution, improving resource allocation.
- Provides real-time dashboards to monitor enrollment velocity and identify sites needing support.
- ROI driver: One pharmaceutical sponsor avoided $4.8M in wasted site activation fees by using AI to select 20% fewer, but higher-performing, sites for a cardiovascular trial.
Reduce Patient Drop-Out & Improve Retention
Patient attrition jeopardizes trial integrity and data. AI identifies patients at high risk of dropping out by analyzing socio-economic factors, travel distance to site, and historical engagement patterns.
- Enables proactive interventions such as arranging transport or telehealth check-ins.
- Integrates with patient-facing apps to personalize communication and support.
- Value proposition: Improving retention by 15% can preserve statistical power, prevent costly protocol amendments, and safeguard the multi-million dollar investment in the trial.
Automate Regulatory Documentation & Feasibility
Study start-up is bogged down by manual document review. AI streamlines feasibility assessments and essential document collection by parsing protocols and site-specific documents.
- Extracts key criteria from trial protocols to auto-generate feasibility questionnaires.
- Accelerates contract and budget reviews by highlighting non-standard clauses.
- Efficiency gain: Cuts study start-up timelines by 3-5 weeks, getting therapies to patients faster and reducing fixed operational costs. This is a critical enabler for agentic enterprise orchestration in clinical operations.
Enabling Efficiency, Speed & Accuracy
Intelligent Analysis, Decision & Execution
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
Talk to Us
Search across company data
Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.
Useful when people spend too long searching or get different answers from different systems.

Automate internal workflows
Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.
Useful when repetitive work moves across multiple tools and teams.

Add AI to products and internal tools
Build assistants, guided actions, or decision support into the software your team or customers already use.
Useful when AI needs to be part of the product, not a separate tool.
Implementation Roadmap: From Pilot to Scale
Transitioning from a successful pilot to enterprise-wide scale is the critical phase where ROI is realized. This roadmap addresses the key technical, compliance, and operational challenges to ensure sustainable value.
The return on investment (ROI) is driven by accelerating trial timelines and reducing operational costs. A successful implementation typically delivers:
- 30-50% faster patient enrollment, reducing the trial's most expensive phase.
- 15-25% increase in site activation by pre-qualifying eligible patients from electronic health records (EHR).
- Significant cost avoidance by reducing manual screening hours and minimizing costly protocol amendments due to poor enrollment.
Quantifiable benefits extend beyond speed. By improving trial diversity and matching accuracy, you enhance data quality and reduce the risk of trial failure, protecting millions in R&D investment. The business case is strongest when the system integrates with existing EHR and clinical data warehouses to maximize data utility.

About the author
Prasad Kumkar
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
Partnered with leading AI, data, and software stack.
How We Work
Custom AI workflows for your Business
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
01
Review the use case
We understand the task, the users, and where AI can actually help.
Read more02
Pick the right approach
We define what needs search, automation, or product integration.
Read more03
Build the first useful version
We implement the part that proves the value first.
Read more04
Improve from there
We add the checks and visibility needed to keep it useful.
Read moreThe first call is a practical review of your use case and the right next step.
Talk to Us